Servier denies bribe allegations as Supreme Court decides on location of Mediator trials
This article was originally published in Scrip
Executive Summary
Servier has categorically denied, via a statement issued on 13 May 2011, media reports that the company telephoned patients who took the controversial slimming diabetes drug Mediator (benfluorex) and offering them money in exchange for dropping their complaints about the drug and claim on the company.